CARLSMED, INC. (CARL)
Carlsmed® Reports First Quarter 2026 Financial Results
Carlsmed® Reports First Quarter 2026 Financial Results
Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BJ’s Wholesale Club Fort Worth Location Set to Open on May 8
Tempus Reports First Quarter 2026 Results
Silvercrest Asset Management (SAMG) to Announce First Quarter 2026 Results and Host Investor Conference Call
Mercury Systems Reports Third Quarter Fiscal 2026 Results
Ligand to Participate in May Investor Conferences
Gulfport Energy Appoints Domenic J. Dell’Osso, Jr. Chief Executive Officer
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa